Oxcarbazepine tablets, a subsidiary of China Resources Shuanghe (600062.SH), obtained a drug registration certificate

Zhitongcaijing · 2d ago

Zhitong Finance App News, China Resources Shuanghe (600062.SH) issued an announcement. Recently, China Resources Shuanghesiang Chinese Medicine (Hunan) Co., Ltd., a holding subsidiary of the company, received the “Drug Registration Certificate” for oxacipine tablets issued by the State Drug Administration. Oxcarbazepine tablets are suitable for the treatment of primary generalized tonic-clonic seizures and partial seizures, with or without secondary full-blown seizures in adults and children 5 years and older. Obtaining the “Drug Registration Certificate” this time is considered to have passed the consistency evaluation.